Premium
Complications of Antifibrinolysis Therapy after Prostatectomy
Author(s) -
WARD M. G.,
RICHARDS B.
Publication year - 1979
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1979.tb02869.x
Subject(s) - medicine , prostatectomy , blood loss , tranexamic acid , urology , surgery , prostate , cancer
Summary— As part of a trial to compare the effectiveness of various agents which have been claimed to reduce blood loss after prostatectomy, tranexamic acid (AMCA) was given pre‐operatively and post‐operatively to 6 patients having routine transurethral resections. Three of these developed ndissoluble intravesical blood clots which persisted until they were evacuated surgically 5 to 17 days after cessation of AMCA therapy. AMCA cannot be recommended for routine use after prostatectomy.